Grail Inc., a cancer-testing startup backed by two of the world’s richest men, is weighing a U.S. initial public offering, people familiar with the matter said, potentially backing away from earlier plans to list in Hong Kong’s volatile market for new health stocks.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
